Bristol Investigating Failed Plavix Settlement With Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb has begun an independent investigation into the company's failed negotiations with Apotex over Plavix, according to a statement posted by the company's board of directors on Bristol's website Aug. 17
You may also be interested in...
Apotex Alleges Bristol/Sanofi Misled Regulators On Plavix Settlement
Bristol/Sanofi made oral commitments to Apotex that were not included in a written settlement, Apotex claims in court documents.
Apotex Alleges Bristol/Sanofi Misled Regulators On Plavix Settlement
Bristol/Sanofi made oral commitments to Apotex that were not included in a written settlement, Apotex claims in court documents.
Plavix Label Gets CLARITY On New Indication: Will Bristol COMMIT To Marketing Effort?
FDA approval comes one day before injunction hearing involving Apotex’ clopidogrel generic.